Besides, XIST was reported to act as a miR-449a sponge to modulate the levels of Bcl-2 and cleaved PARP-1 by attenuating the endogenous function of miR-449a, which consequently influenced tumour progression of NSCLC [55]. The gene discussed is BCL2; the disease is non-small cell lung carcinoma.